Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,324 papers from all fields of science
Search
Sign In
Create Free Account
Oxprenolol:MRat:24H:Urine:Qn
Known as:
???????????:??????:24 ????:????:?????
, Oxprenolol:MRat:24H:Urina:Qn
, Oxprenolol:Massa productiesnelheid:24U:Urine:Kwantitatief
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Oxprenolol
Oxprenolol Hydrochloride
Slow Trasicor
Tevacor
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Twenty-four hour effects of oxprenolol oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion
M. Baak
,
F. Verstappen
,
B. Oosterhuis
European Journal of Clinical Pharmacology
2004
Corpus ID: 22558085
SummaryThe effects of oxprenolol, a non-selective beta-blocker with moderate intrinsic sympathomimetic activity (ISA), given by…
Expand
1992
1992
An interactive computer program for randomization analysis of response curves with facilities for multiple comparisons.
E.S. Tan
,
J.M.A. Roos
,
A. Volovics
,
M.A. Van Baak
,
R.J.M.M. Does
Computers and biomedical research, an…
1992
Corpus ID: 20855062
1986
1986
Antihypertensive activity at rest and during dynamic exercise of oxprenolol oros 16/260 24 hours after dosing: a double-blind comparison with atenolol
L. Corea
,
M. Bentivoglio
,
P. Verdecchia
,
M. Provvidenza
,
M. Motolese
,
C. Valori
1986
Corpus ID: 78146659
1985
1985
Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
P. Bennett
,
J. Bennett
,
+5 authors
S. Warrington
British Journal of Clinical Pharmacology
1985
Corpus ID: 22856246
Oxprenolol was administered in single doses by mouth to healthy volunteers either in a polymer-matrix slow-release formulation…
Expand
1985
1985
Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
F. Müller
,
L. Allsopp
,
+5 authors
F. Bühler
British Journal of Clinical Pharmacology
1985
Corpus ID: 24845324
Nineteen patients receiving oxprenolol slow-release (SR) 160 mg (three patients) or 320 mg (16 patients) once daily for mild to…
Expand
1985
1985
Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy…
J. Moppert
,
P. Degen
,
A. Racine‐Poon
British Journal of Clinical Pharmacology
1985
Corpus ID: 37623736
Plasma drug concentrations and attenuations in sub-maximal exercise tachycardia were measured in six healthy subjects 24 h after…
Expand
1983
1983
Exercise tolerance and echocardiographic assessment of long-term treatment with oxprenolol-bencyclane association in hypertensive patients
D. Bonaduce
,
N. Ferrara
,
G. Morgano
1983
Corpus ID: 79476338
1979
1979
ハロセン麻酔における各種β-遮断薬(propranolol alprenolol oxprenolol CS-359)投与の血行力学的研究
宗広 久保田
,
後藤 康之
,
古川 幸道
1979
Corpus ID: 92899686
1976
1976
β-遮断薬 Oxprenolol の健康人に対する作用(補遺)
三弘 宮崎
1976
Corpus ID: 94379484
1975
1975
β-遮断薬 Oxprenolol の健康人に対する作用
幸雄 和久田
1975
Corpus ID: 101384138
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE